MicroRNA delivery systems in glioma therapy and perspectives: A systematic review

José Marcos Jiménez-Morales, Yanet Elisa Hernández-Cuenca, Ander Reyes-Abrahantes, Henry Ruiz-García, Francisco Barajas-Olmos, Humberto García-Ortiz, Lorena Orozco, Alfredo Quiñones-Hinojosa, Jesús Reyes-González, María del Carmen Abrahantes-Pérez

Research output: Contribution to journalReview articlepeer-review


Gliomas are the deadliest of all primary brain tumors, and they constitute a serious global health problem. MicroRNAs (miRNAs) are gene expression regulators associated with glioma pathogenesis. Thus, miRNAs represent potential therapeutic agents for treating gliomas. However, miRNAs have not been established as part of the regular clinical armamentarium. This systemic review evaluates current molecular and pre-clinical studies with the aim of defining the most appealing supramolecular platform for administering therapeutic miRNA to patients with gliomas. An integrated analysis suggested that cationic lipid nanoparticles, functionalized with octa-arginine peptides, represent a potentially specific, practical, non-invasive intervention for treating gliomas. This supramolecular platform allows loading both hydrophilic (miRNA) and hydrophobic (anti-tumor drugs, like temozolomide) molecules. This systemic review is the first to describe miRNA delivery systems targeted to gliomas that integrate several types of molecules as active ingredients. Further experimental validation is warranted to confirm the practical value of miRNA delivery systems.

Original languageEnglish (US)
Pages (from-to)712-730
Number of pages19
JournalJournal of Controlled Release
StatePublished - Sep 2022


  • Drug delivery system
  • Glioma
  • MicroRNAs
  • Molecular targeted therapy
  • Translational medicine

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'MicroRNA delivery systems in glioma therapy and perspectives: A systematic review'. Together they form a unique fingerprint.

Cite this